GlassScriptPhysician profile
Jeffrey S Miller
NPI 1053497198
$41,286.67
in general payments reported to CMS, 2019-2025
9 companies · $3,913 in 2025
The $3,913 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,197 · 2021: $4,230 · 2022: $4,495 · 2023: $23K · 2025: $3,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,576 · Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,122.50 |
| Travel and Lodging | $3,576.27 |
| Food and Beverage | $665.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17,888.51 | 2022-2023 | |
| Regeneron Pharmaceuticals, INC. | $10,016.63 | 2023 | |
| Sanofi US Services INC. | $5,178.00 | 2020 | |
| Gilead Sciences, INC. | $3,913.03 | 2025 | |
| Chugai Pharmaceutical Co., LTD. | $1,980.00 | 2021 | |
| Genentech, INC. | $1,500.00 | 2021 | |
| Celgene Corporation | $750.00 | 2021 | |
| Glaxosmithkline, LLC. | $41.08 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.